BRIM Biotechnology, Inc. (TPE:6885)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
29.10
+0.55 (1.93%)
Nov 13, 2026, 1:30 PM CST

BRIM Biotechnology Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
12.555.490.330.090.530.36
Revenue Growth
295.59%1548.65%270.00%-82.89%46.11%-99.60%
Gross Profit
-2.051.250.020.090.530.36
Operating Income
-465.82-452.97-344.79-694.13-218.33-93.22
Net Income
-440.46-436.45-315.47-688.02-274.28-105.45
Earnings Per Share
-3.35-3.32-2.70-6.84-3.85-1.78
EPS Growth
------

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Pepsico and Its Subsidiaries
1.37----
Quanfu
4.120.330.090.530.36
Total
5.490.330.090.530.36

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
920.331,1581,8491,696837.99423.59
Total Debt
5.6615.967.783.596.443.16
Net Cash (Debt)
914.671,1421,8411,692831.55420.42
Net Cash Growth
-27.45%-37.94%8.80%103.48%97.79%157.57%
Net Cash Per Share
6.958.6915.7816.8311.667.09

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9.81-329.17-279.24-596.89-171.87-112.57
Capital Expenditures
-2.26-0.8-2.9-2.26-1.11-0.78
Free Cash Flow
-12.07-329.97-282.14-599.15-172.98-113.35
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-16.34%22.77%6.61%100.00%100.00%100.00%
Operating Margin
-3712.29%-8250.89%-103539.04%-771250.00%-41506.84%-25893.06%
Pretax Margin
-3839.85%-8213.30%-94735.74%-764468.89%-52143.92%-29291.39%
Profit Margin
-3510.23%-7949.94%-94735.74%-764468.89%-52143.92%-29291.39%
FCF Margin
-96.20%-6010.38%-84726.73%-665723.33%-32885.74%-31485.83%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
308.58721.8812216.1438520.366763.57-